Eli Lilly (NYSE:LLY) yesterday dosed the first patient in a trial of its automated insulin delivery system.
The system is a hybrid closed-loop platform that includes a connected insulin pump, a dosing algorithm and a continuous glucose monitor.
Get the full story at our sister site, Drug Delivery Business News.
The post Lilly launches trial for automated insulin delivery system appeared first on MassDevice.
from MassDevice http://ift.tt/2kp2OKP
Cap comentari:
Publica un comentari a l'entrada